Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 20

1.

Examining geographic and socio-economic differences in outpatient and inpatient consumer expenditures for treating HIV/AIDS in Nigeria.

Onwujekwe OE, Ibe O, Torpey K, Dada S, Uzochukwu B, Sanwo O.

J Int AIDS Soc. 2016 Feb 1;19(1):20588. doi: 10.7448/IAS.19.1.20588. eCollection 2016.

2.

The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit Analysis.

Meyer-Rath G, Pienaar J, Brink B, van Zyl A, Muirhead D, Grant A, Churchyard G, Watts C, Vickerman P.

PLoS Med. 2015 Sep 1;12(9):e1001869. doi: 10.1371/journal.pmed.1001869. eCollection 2015 Sep.

3.

Cost-Effectiveness of Introducing the SILCS Diaphragm in South Africa.

Lépine A, Nundy N, Kilbourne-Brook M, Siapka M, Terris-Prestholt F.

PLoS One. 2015 Aug 21;10(8):e0134510. doi: 10.1371/journal.pone.0134510. eCollection 2015.

4.

A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda: a prospective observational cohort study.

Siedner MJ, Santorino D, Lankowski AJ, Kanyesigye M, Bwana MB, Haberer JE, Bangsberg DR.

BMC Med. 2015 Jul 6;13:160. doi: 10.1186/s12916-015-0397-1.

5.

Gender-specific risk factors for virologic failure in KwaZulu-Natal: automobile ownership and financial insecurity.

Hare AQ, Ordóñez CE, Johnson BA, Del Rio C, Kearns RA, Wu B, Hampton J, Wu P, Sunpath H, Marconi VC.

AIDS Behav. 2014 Nov;18(11):2219-29. doi: 10.1007/s10461-014-0849-1.

6.

Economic support to patients in HIV and TB grants in rounds 7 and 10 from the global fund to fight AIDS, tuberculosis and malaria.

Richter LM, Lönnroth K, Desmond C, Jackson R, Jaramillo E, Weil D.

PLoS One. 2014 Jan 28;9(1):e86225. doi: 10.1371/journal.pone.0086225. eCollection 2014.

7.

Patient costs associated with accessing HIV/AIDS care in Malawi.

Pinto AD, van Lettow M, Rachlis B, Chan AK, Sodhi SK.

J Int AIDS Soc. 2013 Mar 19;16:18055. doi: 10.7448/IAS.16.1.18055.

8.

A novel Markov model projecting costs and outcomes of providing antiretroviral therapy to public patients in private practices versus public clinics in South Africa.

Leisegang R, Maartens G, Hislop M, Sargent J, Darkoh E, Cleary S.

PLoS One. 2013;8(2):e53570. doi: 10.1371/journal.pone.0053570. Epub 2013 Feb 6.

9.

Toward an understanding of disengagement from HIV treatment and care in sub-Saharan Africa: a qualitative study.

Ware NC, Wyatt MA, Geng EH, Kaaya SF, Agbaji OO, Muyindike WR, Chalamilla G, Agaba PA.

PLoS Med. 2013;10(1):e1001369; discussion e1001369. doi: 10.1371/journal.pmed.1001369. Epub 2013 Jan 8.

10.

Economic evaluation of task-shifting approaches to the dispensing of anti-retroviral therapy.

Foster N, McIntyre D.

Hum Resour Health. 2012 Sep 13;10:32. doi: 10.1186/1478-4491-10-32.

11.
12.

Hospital based palliative care in sub-Saharan Africa; a six month review from Malawi.

Tapsfield JB, Jane Bates M.

BMC Palliat Care. 2011 Jul 9;10:12. doi: 10.1186/1472-684X-10-12.

13.

Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study.

El-Khatib Z, Ekstrom AM, Coovadia A, Abrams EJ, Petzold M, Katzenstein D, Morris L, Kuhn L.

BMC Public Health. 2011 Feb 8;11:88. doi: 10.1186/1471-2458-11-88.

14.

Economic outcomes of patients receiving antiretroviral therapy for HIV/AIDS in South Africa are sustained through three years on treatment.

Rosen S, Larson B, Brennan A, Long L, Fox M, Mongwenyana C, Ketlhapile M, Sanne I.

PLoS One. 2010 Sep 14;5(9):e12731. doi: 10.1371/journal.pone.0012731.

15.

Who is accessing public-sector anti-retroviral treatment in the Free State, South Africa? An exploratory study of the first three years of programme implementation.

Wouters E, Heunis C, Ponnet K, Van Loon F, Booysen Fle R, van Rensburg D, Meulemans H.

BMC Public Health. 2010 Jul 1;10:387. doi: 10.1186/1471-2458-10-387.

16.
17.

Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian setting.

Watt MH, Maman S, Golin CE, Earp JA, Eng E, Bangdiwala SI, Jacobson M.

AIDS Care. 2010 Mar;22(3):381-9. doi: 10.1080/09540120903193708.

18.

Explaining adherence success in sub-Saharan Africa: an ethnographic study.

Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, Agbaji O, Chalamilla G, Bangsberg DR.

PLoS Med. 2009 Jan 27;6(1):e11. doi: 10.1371/journal.pmed.1000011.

19.

Strategies for promoting adherence to antiretroviral therapy: a review of the literature.

Simoni JM, Amico KR, Pearson CR, Malow R.

Curr Infect Dis Rep. 2008 Nov;10(6):515-21.

20.

Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal, South Africa.

Peltzer K, Preez NF, Ramlagan S, Fomundam H.

BMC Public Health. 2008 Jul 24;8:255. doi: 10.1186/1471-2458-8-255.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk